AVBC vs UTHR · rev $130.6M vs P/E 20, rev $1.56B
Avidia Bancorp, Inc. (AVBC) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Avidia Bancorp, Inc. (AVBC) is a banks - regional company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AVBC revenue for 2025-12-31 was $130.6M. Net income was -$3.3M. Revenue was up 5.5% from 2024-12-31 to 2025-12-31. AVBC currently screens at market cap $0.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
AVBC currently screens at market cap $0. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the AVBC and UTHR stock pages for the full models.
Not investment advice.